Cushley M J, Lewis R A, Tattersfield A E
Thorax. 1983 Dec;38(12):908-13. doi: 10.1136/thx.38.12.908.
The relative efficiency of the metered dose inhaler (MDI), the MDI attached to a pear shaped extension tube (PET), and the Inspiron Mini-Neb nebuliser were assessed in eight normal and eight asthmatic subjects. Subjects inhaled the same increasing doses of terbutaline with each technique on different occasions and the response was measured as specific airway conductance (sGaw) and, in the asthmatic patients only, as FEV1. The PET produced greater bronchodilatation than either the MDI or the nebuliser in both normal and asthmatic subjects. Serum terbutaline concentrations were similar after the PET and MDI in the normal subjects, but were lower with the PET in the asthmatic patients. The nebuliser produced about the same amount of bronchodilatation as the MDI--slightly less in the normal subjects and slightly more when assessed as FEV1 in the asthmatic subjects. Serum terbutaline concentrations were lower after the nebuliser than after the MDI in both groups of subjects. For patients with moderately severe airways obstruction requiring large doses of beta agonist, the nebuliser will produce an amount of bronchodilatation similar to the MDI with lower blood levels. Overall, the PET produced greater bronchodilatation than either of the other two methods of inhalation, with low serum terbutaline concentrations similar to those produced by the nebuliser in the asthmatic patients.
在8名正常受试者和8名哮喘患者中评估了定量吸入器(MDI)、连接梨形延长管(PET)的MDI以及Inspiron Mini-Neb雾化器的相对效率。受试者在不同时间用每种技术吸入递增剂量的特布他林,反应以比气道传导率(sGaw)来衡量,仅在哮喘患者中以第一秒用力呼气容积(FEV1)来衡量。在正常受试者和哮喘患者中,PET产生的支气管扩张作用均大于MDI或雾化器。正常受试者使用PET和MDI后血清特布他林浓度相似,但哮喘患者使用PET后的血清特布他林浓度较低。雾化器产生的支气管扩张作用与MDI大致相同——在正常受试者中略少,在哮喘患者中以FEV1评估时略多。两组受试者使用雾化器后的血清特布他林浓度均低于使用MDI后。对于需要大剂量β受体激动剂的中度严重气道阻塞患者,雾化器将产生与MDI相似的支气管扩张作用,且血药浓度较低。总体而言,PET产生的支气管扩张作用大于其他两种吸入方法中的任何一种,哮喘患者血清特布他林浓度较低,与雾化器产生的浓度相似。